CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Elucidating molecular mechanisms of acquired resistance to BRAF inhibitors in melanoma using a microfluidic device and deep sequencing
Jiyeon Han, Yeonjoo Jung, Yukyung Jun, Sungsu Park, Sanghyuk Lee
Genomics Inform. 2021;19(1):e2  Published online March 15, 2021
DOI: https://doi.org/10.5808/gi.20074

Excel Download

Elucidating molecular mechanisms of acquired resistance to BRAF inhibitors in melanoma using a microfluidic device and deep sequencing
Genomics & Informatics. 2021;19(1):e2   Crossref logo
Link1 Link2 Link3

Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma
International Journal of Molecular Sciences. 2020;21(24):9730   Crossref logo
Link1

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
Cancers. 2019;11(8):1176   Crossref logo
Link1

Low inducible expression of p21Cip1 confers resistance to paclitaxel in BRAF mutant melanoma cells with acquired resistance to BRAF inhibitor
Molecular and Cellular Biochemistry. 2015;406(1-2):53-62   Crossref logo
Link1 Link2 Link3

Molecular Mechanisms of Acquired Resistance to Kinase Inhibitors
Annals of Oncology. 2012;23:ix51   Crossref logo
Link1 Link2

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
Biochemical Pharmacology. 2011;82(3):201-209   Crossref logo
Link1 Link2

The path of least resistance: enhancing the effectiveness of BRAF inhibitors
Pigment Cell & Melanoma Research. 2013;26(3):296-297   Crossref logo
Link1 Link2

Integrative RNAseq and target panel sequencing reveals common and distinct innate and adaptive resistance mechanisms to BRAF inhibitors
Annals of Oncology. 2019;30:v547   Crossref logo
Link1 Link2 Link3

RAC1 P29S as a marker of resistance to BRAF inhibitors in melanoma
Science-Business eXchange. 2014;7(33):1000-1000   Crossref logo
Link1 Link2 Link3

Metabolic rewiring in melanoma cell lines that acquired resistance to BRAF inhibitors
European Journal of Cancer. 2016;61:S55-S56   Crossref logo
Link1 Link2